These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 25180131

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
    Ito S, Torii T, Nakajima A, Iijima T, Murano H, Horiuchi H, Yamanaka H, Honda M.
    BMC Pediatr; 2020 Oct 15; 20(1):481. PubMed ID: 33059648
    [Abstract] [Full Text] [Related]

  • 24. The effect of resveratrol on the recurrent attacks of gouty arthritis.
    Chen H, Zheng S, Wang Y, Zhu H, Liu Q, Xue Y, Qiu J, Zou H, Zhu X.
    Clin Rheumatol; 2016 May 15; 35(5):1189-95. PubMed ID: 25451618
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Hyperuricemia and gout : New aspects of an old disease].
    Witt M, Schulze-Koops H.
    Internist (Berl); 2016 Jul 15; 57(7):656-65. PubMed ID: 27286837
    [Abstract] [Full Text] [Related]

  • 27. Outcome of Treatment in Gouty Arthritis Patients: A Retrospective Study.
    Hanvivadhanakul P, Wongdet R.
    J Med Assoc Thai; 2015 Apr 15; 98 Suppl 3():S46-50. PubMed ID: 26387388
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S.
    Nihon Rinsho; 2008 Apr 15; 66(4):729-35. PubMed ID: 18409523
    [Abstract] [Full Text] [Related]

  • 31. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT, Hsieh SC, Hsieh TY, Hsu PF, Kuo CF, Kuo MC, Lam HC, Lee IT, Liang TH, Lin HY, Lin SC, Tsai WP, Tsay GJ, Wei JC, Yang CH, Tsai WC.
    Int J Rheum Dis; 2018 Apr 15; 21(4):772-787. PubMed ID: 29363262
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of Hyperuricemia and Gouty Arthritis in BALB/c Mice Using Copper Oxide Nanoparticles.
    Kiyani MM, Rehman H, Hussain MA, Jahan S, Afzal M, Nawaz I, Mahmood T, Bokhari SAI.
    Biol Trace Elem Res; 2020 Feb 15; 193(2):494-501. PubMed ID: 31079329
    [Abstract] [Full Text] [Related]

  • 33. Gout and hyperuricemia.
    Chilappa CS, Aronow WS, Shapiro D, Sperber K, Patel U, Ash JY.
    Compr Ther; 2010 Feb 15; 36():3-13. PubMed ID: 21229813
    [Abstract] [Full Text] [Related]

  • 34. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X, Zhai T, Ma R, Luo C, Wang H, Liu L.
    Ren Fail; 2018 Nov 15; 40(1):289-297. PubMed ID: 29619870
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Advances in the management of gout and hyperuricaemia.
    Hoskison TK, Wortmann RL.
    Scand J Rheumatol; 2006 Nov 15; 35(4):251-60. PubMed ID: 16882587
    [Abstract] [Full Text] [Related]

  • 39. A study of uric acid metabolism and gouty arthritis in patients with polycystic kidney.
    Hosoya T, Ichida K, Tabe A, Sakai O.
    Nihon Jinzo Gakkai Shi; 1993 Jan 15; 35(1):43-8. PubMed ID: 8336399
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.